Coverage Initiated On GW Pharmaceuticals

Morgan Stanley initiated coverage of GW Pharmaceuticals (Nasdaq: GWPH) with an Overweight rating and a price target of $103 sending the stock price soaring $15.88 to $61.92.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.